BCM
VCYT icon

Bluefin Capital Management’s Veracyte VCYT Stock Holding History

Bluefin Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-35,000
Closed -$22K – 733
2015
Q4 		$22K Buy
+35,000
New +$236K ﹤0.01% 552

Other funds holding VCYT

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bluefin Capital Management's VCYT Position: Q1 2016 in Review

Bluefin Capital Management sold out of Veracyte (VCYT) in Q1 2016, closing a stake of 35,000 shares — an estimated $252K sold.

Bluefin Capital Management first reported a position in VCYT in Q4 2015 and held it in 1 quarter. The position peaked at $252K in Q4 2015. 55 funds tracked by Wall St. Rank hold VCYT as of Q1 2016.

  • Bluefin Capital Management reported no remaining Veracyte position as of Q1 2016 after selling out during the quarter.
  • Bluefin Capital Management sold 35,000 Veracyte shares in Q1 2016, an estimated $252K.
  • Bluefin Capital Management first reported a position in Veracyte in Q4 2015 and held it in 1 quarter.
  • Bluefin Capital Management's Veracyte position peaked at $252K in Q4 2015.
  • 55 funds tracked by Wall St. Rank held Veracyte as of Q1 2016.

Based on Bluefin Capital Management's 13F filing for Q1 2016, filed 16 May 2016.